NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹135.63
0.70%
NAV as on 30 Apr 24, 12:00 AM
very high risk
mid cap
equity
NAV as on 30 Apr 24, 12:00 AM
very high risk
mid cap
equity
50.43%p.a.
Last 1Y
25.32%p.a.
Last 3Y
23.00%p.a.
Last 5Y
16.29%p.a.
Since Inception
NRIs can achieve long-term capital appreciation by investing in the Invesco India Mid Cap Fund Growth scheme from Invesco Asset Management (India) Private Ltd. It is a Mid-Cap mutual fund scheme that predominantly invests in Mid-Cap stocks of companies. Launched on Apr 2007, Invesco India Mid Cap Fund Growth is Mid-Cap fund of its category with 5,517.29 Cr fund under management as on Apr 2024. The expense ratio of this fund is less than that of most other Fund category Mid-Cap funds.
To generate capital appreciation by investing predominantly in Midcap companies.
Trent Ltd
5.04%
Max Healthcare Institute Ltd Ordinary Shares
4.30%
Cholamandalam Investment and Finance Co Ltd
4.27%
The Federal Bank Ltd
4.03%
L&T Finance Holdings Ltd
3.65%
Kalyan Jewellers India Ltd
3.61%
Dixon Technologies (India) Ltd
3.33%
Prestige Estates Projects Ltd
3.27%
Max Financial Services Ltd
3.24%
Mankind Pharma Ltd
3.23%
View Scheme Document
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
---|---|---|
Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
If all details are correct, your KYC will be approved within 7 to 8 business days.
Funds
3Y Return
very high risk | equity
29.7%
very high risk | equity
23.8%
very high risk | equity
20.1%